Celgene-backed drug company PTC Therapeutics has raised $30m.
Other backers of the round raised by PTC were Credit Suisse First Boston Equity Partners, part of the Switzerland-based bank, as well as venture firms HBM BioVentures, Vulcan Ventures, Delphi Ventures, The Column Group, and Denmark-based foundation Novo.